Tanaka Capital Management Inc Bristol Myers Squibb CO Transaction History
Tanaka Capital Management Inc
- $55.5 Million
- Q3 2025
A detailed history of Tanaka Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tanaka Capital Management Inc holds 166 shares of BMY stock, worth $7,770. This represents 0.01% of its overall portfolio holdings.
Number of Shares
166
Previous 166
-0.0%
Holding current value
$7,770
Previous $10,000
30.0%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...